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The commentary of Morriss et al. on our recent meta-analysis of functional magnetic 
resonance imaging (fMRI) fear/threat extinction studies in humans (Fullana et al., 2018) 
raises some important issues for future research in the field. In essence, they argue that 
the lack of consistent evidence for amygdala and ventromedial prefrontal cortex 
(vmPFC) involvement in these studies, as summarized by meta-analysis, might be partly 
due to the fact that very few of these studies have provided appropriate analyses of 
time-varying neural responses, which Morriss et al. contend should be the gold 
standard.  
Fear/threat conditioning and extinction learning are indeed incremental processes that 
develop on a trial-by-trial level (Rescorla and Wagner, 1972), and thus including trial 
factors in fMRI analyses of these processes may conceivably improve their 
characterization. However, we would like to reiterate our position on a couple of issues, 
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which we believe may more fundamentally influence the characterization of these 
regions in fMRI studies of conditioning and extinction processes. 
First, the analysis of participant responses in fMRI threat/fear learning studies typically 
indicate states of mild anticipatory anxiety, and relief thereof, when contrasting CS+ 
and CS-, respectively. In addition, we can assume that participants are fully aware that 
their involvement in these experiments is safe, and that no genuine threat exists to their 
well-being. Thus, a more compelling explanation of the absence of amygdala 
involvement across fMRI fear/threat learning experiments might be that these 
experiments themselves are not strong probes of amygdala defense-survival circuit 
function. In other words, regardless of the application of time-varying analyses of 
amygdala responses, coupled with higher resolution imaging etc., these experiments 
may not be capable of eliciting the types or magnitudes of threat that have been shown 
to routinely elicit defense-survival responses in animal studies. By way of illustration, 
the results of our former meta-analysis of fMRI fear/threat conditioning studies (Fullana 
et al., 2016) lead one anonymous reviewer to remark: “the authors would do the 
community a great favor if they finally put away with the amygdalo-centric view on 
human fear conditioning (that is more based on rodent data than on any actual data from 
humans) and emphasized the role of other, mainly cortical, structures that are observed 
much more consistently”. Accordingly, we feel that whilst innovations in modelling 
neural dynamics in fMRI fear/threat learning studies will be important in the future 
progress of this work, we should also confront the idea that these experiments may be 
fundamentally limited in the study of neural defense-survival circuits and may be better 
suited to addressing other aspects of the experience of threat/fear/anxiety and related 
mental states (see Fullana et al., 2016).   
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Second, the absence of consistent vmPFC involvement in the fear/threat extinction 
learning meta-analysis may originate in the test comparisons used to detect neural 
correlates of extinction in humans. As we have discussed at length in other work 
(Fullana et al., 2016; Harrison et al., 2017), vmPFC activation is reliably observed when 
the conditioning of safety (CS-) is compared to the conditioning of threat (CS+), and 
this differential response generalizes well across fear/threat learning states and contexts. 
But in extinction learning studies, the characterization of vmPFC responses has likely 
been confounded by choice of comparison (baseline) condition. For example, in all 
studies included in our meta-analysis, the primary fear extinction learning contrast was 
based on the comparison of responses to extinction CS+ ('now safe') vs. CS- (‘still 
safe’) stimuli. Using the latter as a ‘baseline’ condition is problematic, because any 
vmPFC activation to the ‘now safe’ signal (extinction CS+) will be largely subtracted 
out against continued vmPFC activation to the ‘still safe’ signal (extinction CS-). 
Indeed, our meta-analysis of extinction recall studies demonstrated reliable vmPFC 
activation in studies that compared extinguished CS+ to unextinguished (‘still 
dangerous’) CS+, but not in studies that compared extinguished CS+ to ‘still safe’ CS-.   
In summary, we agree with Morris et al. that analyzing the trial factor is an important 
goal for future studies on fear and extinction learning, but we also highlight the 
challenges of (1) probing the survival-defensive circuit within the safety boundaries of  
human threat/fear learning experiments, and (2) identifying neutral baseline 
comparisons that are not contaminated by safety during extinction learning. Possible 
solutions lie in the use of fear-relevant stimuli as conditioned stimuli (see Mineka and 
Öhman, 2002) and in the use of a baseline phase prior to conditioning as a more neutral 
comparison state (Harrison et al., 2017).   
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